This announcement is a separate document:
大幸薬品：2023年12月期（FY2023）連結決算報告
Taiko Pharmaceutical: Consolidated financial results report for the fiscal year ending 2023/12 (FY2023)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.